Phio Pharmaceuticals to present at NIBA 153rd Conference, updates PH-762 program
PHIO•Phio Pharmaceuticals will present at NIBA’s 153rd Conference in Fort Lauderdale on Oct. 6-7, 2026, with CEO Robert Bitterman scheduled to speak Oct. 7 at 12:40 p.m. EDT and provide a PH-762 development update.
1. Conference presentation
Phio Pharmaceuticals said its presentation will cover the INTASYL siRNA platform, its delivery approach and strategic direction, along with a development update on PH-762 in cutaneous squamous cell carcinoma.
